Tamarisk Technologies Group Announces Partnership with Engineered BioPharmaceuticals and Exciting Developments in Their MxBA™ Technology
LOS ANGELES, June 11, 2015 /PRNewswire/ -- Tamarisk Technologies Group, LLC, a technology development company engaged in the development of innovative drug delivery technology announced last week that it has partnered with Engineered BioPharmaceuticals, Inc. http://www.engbiopharm.com/ for the integration of application specific product features and the manufacture of pilot quantities of Tamarisk's novel MxBA™ oral delivery product.
Logo - http://photos.prnewswire.com/prnh/20150611/222591LOGO
Photo - http://photos.prnewswire.com/prnh/20150611/222592
"We are very excited about our partnership with eBio," says Dean Crowell, Executive Director of Tamarisk Technologies Group. "They bring a wealth of experience in drug delivery technology development and will be instrumental as we continue to improve our MxBA platform. The scientists at eBio have already made great strides refining our process and have innovated several new approaches to perfect our delivery vehicle."
"We are extremely pleased to be part of this endeavor!" says Carl Sahi, President of eBio. "There is definite excitement here and we have seen some dramatic results. Tamarisk's platform protects the active molecule's integrity and cleverly maximizes oral absorption. This vehicle addresses multiple challenges and will undoubtedly revolutionize the drug delivery market!"
Tamarisk has been working these past few months refining their processes and has completed several studies, including an animal study at Charles River and cell culture studies at VaxForm. "We were very pleased with the results of our recent trials at Charles River," says A.T. Snoots, Tamarisk's Director of Operations. "This study helped us validate our technology and we noted impressive results in increased bioavailability. Our cell culture study helped us clearly define the mechanism of absorption. "
Leadership from the Tamarisk team as well as Executives from eBio will be at the Bio 2015 conference in Philadelphia and are looking for partnering opportunities.
About Tamarisk Technologies Group LLC
Tamarisk Technologies Group is a scientific research and development company that has recently undergone significant organizational changes. At Tamarisk, we are engaged in the invention of all-natural therapeutic agents, drug delivery transport vehicles, "green chemistry" for production of innovative products and manufacturing processes, and the provision of high-value technologies that exceed the confines of traditional scientific philosophy.
About Engineered BioPharmaceuticals
Engineered BioPharmaceuticals is a forward thinking pharmaceutical, engineering and manufacturing company dedicated to advancing state-of-the-art medicine while reducing its cost.
Media Contact: A. T. Snoots, (for Tamarisk Technologies), 805-796-6084, Email
SOURCE Tamarisk Technologies Group LLC
Share this article